-
Je něco špatně v tomto záznamu ?
LACE1 interacts with p53 and mediates its mitochondrial translocation and apoptosis
J. Cesnekova, J. Spacilova, H. Hansikova, J. Houstek, J. Zeman, L. Stiburek,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
NLK
Free Medical Journals
od 2010
PubMed Central
od 2010
Europe PubMed Central
od 2010
Open Access Digital Library
od 2010-01-01
PubMed
27323408
DOI
10.18632/oncotarget.9959
Knihovny.cz E-zdroje
- MeSH
- adenosintrifosfatasy metabolismus MeSH
- apoptóza fyziologie MeSH
- HEK293 buňky MeSH
- lidé MeSH
- mitochondriální proteiny metabolismus MeSH
- mitochondrie metabolismus MeSH
- nádorový supresorový protein p53 metabolismus MeSH
- transfekce MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
p53 is a major cellular tumor suppressor that in addition to its nuclear, transcription-dependent activity is also known to function extranuclearly. Cellular stressors such as reactive oxygen species can promote translocation of p53 into mitochondria where it acts to protect mitochondrial genome or trigger cell death via transcription-independent manner. Here we report that the mammalian homologue of yeast mitochondrial Afg1 ATPase (LACE1) promotes translocation of p53 into mitochondria. We further show that LACE1 exhibits significant pro-apoptotic activity, which is dependent on p53, and that the protein is required for normal mitochondrial respiratory function. LACE1 physically interacts with p53 and is necessary for mitomycin c-induced translocation of p53 into mitochondria. Conversely, increased expression of LACE1 partitions p53 to mitochondria, causes reduction in nuclear p53 content and induces apoptosis. Thus, LACE1 mediates mitochondrial translocation of p53 and its transcription-independent apoptosis.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18011154
- 003
- CZ-PrNML
- 005
- 20180404142605.0
- 007
- ta
- 008
- 180404s2016 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.18632/oncotarget.9959 $2 doi
- 035 __
- $a (PubMed)27323408
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Cesnekova, Jana $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
- 245 10
- $a LACE1 interacts with p53 and mediates its mitochondrial translocation and apoptosis / $c J. Cesnekova, J. Spacilova, H. Hansikova, J. Houstek, J. Zeman, L. Stiburek,
- 520 9_
- $a p53 is a major cellular tumor suppressor that in addition to its nuclear, transcription-dependent activity is also known to function extranuclearly. Cellular stressors such as reactive oxygen species can promote translocation of p53 into mitochondria where it acts to protect mitochondrial genome or trigger cell death via transcription-independent manner. Here we report that the mammalian homologue of yeast mitochondrial Afg1 ATPase (LACE1) promotes translocation of p53 into mitochondria. We further show that LACE1 exhibits significant pro-apoptotic activity, which is dependent on p53, and that the protein is required for normal mitochondrial respiratory function. LACE1 physically interacts with p53 and is necessary for mitomycin c-induced translocation of p53 into mitochondria. Conversely, increased expression of LACE1 partitions p53 to mitochondria, causes reduction in nuclear p53 content and induces apoptosis. Thus, LACE1 mediates mitochondrial translocation of p53 and its transcription-independent apoptosis.
- 650 _2
- $a adenosintrifosfatasy $x metabolismus $7 D000251
- 650 _2
- $a apoptóza $x fyziologie $7 D017209
- 650 _2
- $a HEK293 buňky $7 D057809
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mitochondrie $x metabolismus $7 D008928
- 650 _2
- $a mitochondriální proteiny $x metabolismus $7 D024101
- 650 _2
- $a transfekce $7 D014162
- 650 _2
- $a nádorový supresorový protein p53 $x metabolismus $7 D016159
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Spacilova, Jana $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
- 700 1_
- $a Hansikova, Hana $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
- 700 1_
- $a Houstek, Josef $u Institute of Physiology, Academy of Sciences of The Czech Republic, Prague, Czech Republic.
- 700 1_
- $a Zeman, Jiri $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
- 700 1_
- $a Stiburek, Lukas $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
- 773 0_
- $w MED00184852 $t Oncotarget $x 1949-2553 $g Roč. 7, č. 30 (2016), s. 47687-47698
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27323408 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20180404142645 $b ABA008
- 999 __
- $a ok $b bmc $g 1288639 $s 1007966
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 7 $c 30 $d 47687-47698 $i 1949-2553 $m Oncotarget $n Oncotarget $x MED00184852
- LZP __
- $a Pubmed-20180404